Here - EWMA 2013

POSTER: DRESSINGS
Poster: Dressings
P 284
A OZONE PRODUCER OIL IN THE TREATMENT OF RECALCITRANT
CHRONIC WOUNDS
AnnaMaria Ippolito 1 , Paolo Cuffaro 1 , Alessandro Corsi 1 , Ornella Forma 2 ,
Roberto Cassino 1
1 Vulnera – Italian Vulnological Center (Turin, Italy);
2 San Raffaele Hospital (Milan, Italy).
Aim: The most of recalcitrant chronic wounds needs a better “breathing” and this means
that we have to give more oxygen to these wounds. The wound bed preparation target is
to transform a chronic wound into an acute one, which is a wounds that is going to heal:
every wound needs oxygen to heal. Aim of the work is to demonstrate the effectiveness
of a hyperoxydated oils gel in the management of recalcitrant wounds, especially in
terms of promoting granulation, improving WBP score, avoiding colonization and to
prove its “easy to use” property.
Methods: The product we are testing is a hyperoxydated oils gel with filmogenic and
protective function, also from the thermal point of view; it accelerates re-epithelialization
promoting the proliferation of fibroblasts, as well as the secretion of cytokines and
growth factors with consequent endogenous angiogenesis. Due to the strong oxidizing
properties, it helps to control microbial growth. The study involves 50 patients with
recalcitrant chronic ulcers of known aetiology, without signs of critical colonization and
WBP score A and/or B with any amount of exudate. All patients must have 0.7 as
minimum Ankle-Brachial Index; terminal and/or cancer patients and/or in
immunosuppressive therapy have been (and will be) excluded. The dressing consists of
applying an omogeneous layer of gel on the lesion, after cleansing with a chloroxidating
solution (hypochlorite 0.05%); moist gauzes as secondary dressing. The renewal of the
dressing was provided every 48 hours. The effectiveness demonstration provides the
evaluation of WBP score changes and the area reduction after an observation period of
4 weeks.
Results: We have observed a mean area reduction of about 54% in all the patients;
WBP score improved in more than 90% of patients with score B; pain reduction was
reported by every patients involved with a mean decreasing of about 58%: in 7 patients
the pain disappeared and more than 50% reduced the use of analgesic drugs.
Conclusions: The dressing showed real effectiveness, promoting granulation and
accelerating epithelialisation within a very few time; no patient had allergy/intolerance
and all of them reported a decreasing of pain, until the complete relief.
AM.Ippolito, P.Cuffaro, A.Corsi, O.Forma, R.Cassino
P 285
Evaluation of a super absorbent Pro-ionic copolymer gel
Poster: Dressings
Sylvie Hampton 1 , Tadej Martin 1 , Bree-Aslan Cathie 1
1 Eastbourne Wound Healing Centres (Eastbourne, United Kingdom).
Aim: To evaluate the performance of the Pro-ionic Copolymer Gel (PiCG) dressing in
moisture management, wound bed preparation and wound bed granulation in 10 patients with
chronic wounds divided over 2 cohorts
Methods:
• Subjects were treated over 6 or 7 visits for up to 4 weeks using the PiCG dressing
• 1st cohort (5 patients) were treated using the PiCG as a primary dressing only
• 2nd cohort (5 patients) were treated using the PiCG initially as a primary dressing until
debridement was achieved, then the PiCG was used as the secondary dressing
• All subjects were seen within the Eastbourne Wound Healing Centre (EWHC)
• Photographs were obtained on each visit
• pH was tested on each visit
• Lined buckets of tap water were used for leg cleansing
• Qualitative and quantitative data and wound progress was recorded in CRFs
• Wound measurements were obtained with Digital Planimetry
• Protease levels were recorded in some instances, as feasible
• All subjects had ultrasound doppler assessment to measure Ankle Brachial Pressure
Indices (ABPI) prior to treatment
• Subjects had a range of wounds including diabetic foot ulcer, venous and arterial leg
ulceration
Results:
• Wound size increased in 80% of the subjects in the 1st cohort; this was due to poor
dressing application techniques which was addressed for the 2nd cohort
• 100% of subjects in the 2nd cohort had a decrease in wound size
• Equally, pain levels in cohort 1 were found to increase whereas 80% of subjects within
cohort 2 had a decrease in pain levels; 1 subject (cohort 2) had an increase in pain levels
• Cohort 2 used PiCG as a primary dressing in the initial stages to facilitate wound bed
preparation; during this period, 80% saw no change in the size of the wound bed whilst
20% saw a slight increase in the size of the wound
• Debridement of the wound was achieved within 2 weeks using the PiCG
• Clinicians found it easy to apply and remove each clinician stated they would wish to use
the product in future treatment regimes
• The PiCG dressing was found to be effective both as a primary dressing but also as a
secondary dressing, aiding absorbency
• The PiCG provided a degree of offloading in the diabetic foot ulcers and appeared to
reduce shear and friction
• The dressing remained intact in all instances with no incidence of desiccation and no need
for irrigation of the wound following removal
Conclusions: This evaluation demonstrated the multi-usage of a PiCG dressing across a
range of chronic wounds coupled with ease of application and removal
EWMA 2013
COPENHAGEN
15-17 May · 2013
Danish Wound
Healing Society
171